Global Schizophrenia Therapeutic Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Sep-2018   |    Format : PDF   |    Pages : 93
Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.
The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation.
In 2017, the global Schizophrenia Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Schizophrenia Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Schizophrenia Therapeutic development in United States, Europe and China.


The key players covered in this study
    Eli Lilly
    Johnson and Johnson
    Pfizer
    Astrazeneca
    Bristol-Myers Squibb
    ...

Market segment by Type, the product can be split into
    Clozapine
    Ziprasidone
    Risperidone
    Lurasidone
    Paliperidone

Market segment by Application, split into
    Hospitals
    Clinics
    Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Schizophrenia Therapeutic status, future forecast, growth opportunity, key market and key players.
    To present the Schizophrenia Therapeutic development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Schizophrenia Therapeutic are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Schizophrenia Therapeutic Market Size Growth Rate by Type (2013-2025)
        1.4.2 Clozapine
        1.4.3 Ziprasidone
        1.4.4 Risperidone
        1.4.5 Lurasidone
        1.4.6 Paliperidone
    1.5 Market by Application
        1.5.1 Global Schizophrenia Therapeutic Market Share by Application (2013-2025)
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Ambulatory Surgical Centers
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Schizophrenia Therapeutic Market Size
    2.2 Schizophrenia Therapeutic Growth Trends by Regions
        2.2.1 Schizophrenia Therapeutic Market Size by Regions (2013-2025)
        2.2.2 Schizophrenia Therapeutic Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Schizophrenia Therapeutic Market Size by Manufacturers
        3.1.1 Global Schizophrenia Therapeutic Revenue by Manufacturers (2013-2018)
        3.1.2 Global Schizophrenia Therapeutic Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Schizophrenia Therapeutic Market Concentration Ratio (CR5 and HHI)
    3.2 Schizophrenia Therapeutic Key Players Head office and Area Served
    3.3 Key Players Schizophrenia Therapeutic Product/Solution/Service
    3.4 Date of Enter into Schizophrenia Therapeutic Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Schizophrenia Therapeutic Market Size by Type (2013-2018)
    4.2 Global Schizophrenia Therapeutic Market Size by Application (2013-2018)

5 United States
    5.1 United States Schizophrenia Therapeutic Market Size (2013-2018)
    5.2 Schizophrenia Therapeutic Key Players in United States
    5.3 United States Schizophrenia Therapeutic Market Size by Type
    5.4 United States Schizophrenia Therapeutic Market Size by Application

6 Europe
    6.1 Europe Schizophrenia Therapeutic Market Size (2013-2018)
    6.2 Schizophrenia Therapeutic Key Players in Europe
    6.3 Europe Schizophrenia Therapeutic Market Size by Type
    6.4 Europe Schizophrenia Therapeutic Market Size by Application

7 China
    7.1 China Schizophrenia Therapeutic Market Size (2013-2018)
    7.2 Schizophrenia Therapeutic Key Players in China
    7.3 China Schizophrenia Therapeutic Market Size by Type
    7.4 China Schizophrenia Therapeutic Market Size by Application

8 Japan
    8.1 Japan Schizophrenia Therapeutic Market Size (2013-2018)
    8.2 Schizophrenia Therapeutic Key Players in Japan
    8.3 Japan Schizophrenia Therapeutic Market Size by Type
    8.4 Japan Schizophrenia Therapeutic Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Schizophrenia Therapeutic Market Size (2013-2018)
    9.2 Schizophrenia Therapeutic Key Players in Southeast Asia
    9.3 Southeast Asia Schizophrenia Therapeutic Market Size by Type
    9.4 Southeast Asia Schizophrenia Therapeutic Market Size by Application

10 India
    10.1 India Schizophrenia Therapeutic Market Size (2013-2018)
    10.2 Schizophrenia Therapeutic Key Players in India
    10.3 India Schizophrenia Therapeutic Market Size by Type
    10.4 India Schizophrenia Therapeutic Market Size by Application

11 Central & South America
    11.1 Central & South America Schizophrenia Therapeutic Market Size (2013-2018)
    11.2 Schizophrenia Therapeutic Key Players in Central & South America
    11.3 Central & South America Schizophrenia Therapeutic Market Size by Type
    11.4 Central & South America Schizophrenia Therapeutic Market Size by Application

12 International Players Profiles
    12.1 Eli Lilly
        12.1.1 Eli Lilly Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Schizophrenia Therapeutic Introduction
        12.1.4 Eli Lilly Revenue in Schizophrenia Therapeutic Business (2013-2018)
        12.1.5 Eli Lilly Recent Development
    12.2 Johnson and Johnson
        12.2.1 Johnson and Johnson Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Schizophrenia Therapeutic Introduction
        12.2.4 Johnson and Johnson Revenue in Schizophrenia Therapeutic Business (2013-2018)
        12.2.5 Johnson and Johnson Recent Development
    12.3 Pfizer
        12.3.1 Pfizer Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Schizophrenia Therapeutic Introduction
        12.3.4 Pfizer Revenue in Schizophrenia Therapeutic Business (2013-2018)
        12.3.5 Pfizer Recent Development
    12.4 Astrazeneca
        12.4.1 Astrazeneca Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Schizophrenia Therapeutic Introduction
        12.4.4 Astrazeneca Revenue in Schizophrenia Therapeutic Business (2013-2018)
        12.4.5 Astrazeneca Recent Development
    12.5 Bristol-Myers Squibb
        12.5.1 Bristol-Myers Squibb Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Schizophrenia Therapeutic Introduction
        12.5.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutic Business (2013-2018)
        12.5.5 Bristol-Myers Squibb Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Schizophrenia Therapeutic Key Market Segments
    Table Key Players Schizophrenia Therapeutic Covered
    Table Global Schizophrenia Therapeutic Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Schizophrenia Therapeutic Market Size Market Share by Type 2013-2025
    Figure Clozapine Figures
    Table Key Players of Clozapine
    Figure Ziprasidone Figures
    Table Key Players of Ziprasidone
    Figure Risperidone Figures
    Table Key Players of Risperidone
    Figure Lurasidone Figures
    Table Key Players of Lurasidone
    Figure Paliperidone Figures
    Table Key Players of Paliperidone
    Table Global Schizophrenia Therapeutic Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Clinics Case Studies
    Figure Ambulatory Surgical Centers Case Studies
    Figure Schizophrenia Therapeutic Report Years Considered
    Table Global Schizophrenia Therapeutic Market Size 2013-2025 (Million US$)
    Figure Global Schizophrenia Therapeutic Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Schizophrenia Therapeutic Market Size by Regions 2013-2025 (Million US$)
    Table Global Schizophrenia Therapeutic Market Size by Regions 2013-2018 (Million US$)
    Table Global Schizophrenia Therapeutic Market Share by Regions 2013-2018
    Figure Global Schizophrenia Therapeutic Market Share by Regions 2013-2018
    Figure Global Schizophrenia Therapeutic Market Share by Regions 2018
    Table Market Top Trends
    Table Global Schizophrenia Therapeutic Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Schizophrenia Therapeutic Market Share by Manufacturers (2013-2018)
    Figure Global Schizophrenia Therapeutic Market Share by Manufacturers in 2018
    Table Global Schizophrenia Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Schizophrenia Therapeutic Product/Solution/Service
    Table Date of Enter into Schizophrenia Therapeutic Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table Global Schizophrenia Therapeutic Market Size Share by Type (2013-2018)
    Figure Global Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
    Table Global Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table Global Schizophrenia Therapeutic Market Size Share by Application (2013-2018)
    Figure Global Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
    Figure Global Schizophrenia Therapeutic Revenue Market Share by Application in 2017
    Figure United States Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table United States Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table United States Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table United States Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table United States Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table United States Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table United States Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure Europe Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table Europe Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table Europe Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table Europe Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table Europe Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table Europe Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table Europe Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure China Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table China Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table China Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table China Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table China Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table China Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table China Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure Japan Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table Japan Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table Japan Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table Japan Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table Japan Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table Japan Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table Japan Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure Southeast Asia Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table Southeast Asia Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table Southeast Asia Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure India Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table India Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table India Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table India Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table India Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table India Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table India Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Figure Central & South America Schizophrenia Therapeutic Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Schizophrenia Therapeutic Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Schizophrenia Therapeutic Market Share (2017-2018)
    Table Central & South America Schizophrenia Therapeutic Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Schizophrenia Therapeutic Market Share by Type (2013-2018)
    Table Central & South America Schizophrenia Therapeutic Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Schizophrenia Therapeutic Market Share by Application (2013-2018)
    Table Eli Lilly Company Details
    Table Eli Lilly Revenue in Schizophrenia Therapeutic Business (2013-2018) (Million US$)
    Figure Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutic Business (2013-2018)
    Table Eli Lilly Recent Development
    Table Johnson and Johnson Company Details
    Table Johnson and Johnson Revenue in Schizophrenia Therapeutic Business (2013-2018)(Million US$)
    Figure Johnson and Johnson Revenue Growth Rate in Schizophrenia Therapeutic Business (2013-2018)
    Table Johnson and Johnson Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Schizophrenia Therapeutic Business (2013-2018)(Million US$)
    Figure Pfizer Revenue Growth Rate in Schizophrenia Therapeutic Business (2013-2018)
    Table Pfizer Recent Development
    Table Astrazeneca Company Details
    Table Astrazeneca Revenue in Schizophrenia Therapeutic Business (2013-2018)(Million US$)
    Figure Astrazeneca Revenue Growth Rate in Schizophrenia Therapeutic Business (2013-2018)
    Table Astrazeneca Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Schizophrenia Therapeutic Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutic Business (2013-2018)
    Table Bristol-Myers Squibb Recent Development
    Table Global Schizophrenia Therapeutic Market Size by Regions (Million US$) 2018-2025
    Figure Global Schizophrenia Therapeutic Market Size Share by Regions (2018-2025)
    Figure Global Schizophrenia Therapeutic Market Size Share by Regions in 2025
    Figure United States Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure China Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure India Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Schizophrenia Therapeutic Market Size Forecast (2018-2025)(Million USD)
    Table Global Schizophrenia Therapeutic Market Size by Product (2018-2025) (Million US$)
    Figure Global Schizophrenia Therapeutic Market Size by Product (2018-2025)
    Figure Global Schizophrenia Therapeutic Market Size by Product in 2025
    Table Global Schizophrenia Therapeutic Market Size by Application (2018-2025) (Million US$)
    Figure Global Schizophrenia Therapeutic Market Size by Application (2018-2025)
    Figure Global Schizophrenia Therapeutic Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...